Open Access

Glad tidings for haemophilia B patients


1. Biggs R, Douglas AS, Macfarlane RC, Dacie JV, Pitney WR, Merskey C, O’Brien JR. Christmas Disease. BMJ 1952; 2: 1378. doi: in Google Scholar

2. Rogaev EI, Grigorenko AP, Faskhutdinova G, Kittler EL, Moliaka YK. Genotype Analysis Identifies the Cause of the “Royal Disease”. Science 2009: 326; 817. doi: 10.1126/science.1180660.Search in Google Scholar

3. Quick AJ, Hussey CV. Hemophilia B QPTC deficiency, or Christmas diseaseR. Arch Intern Med 1959; 103: 762S75. doi:10.1001/archinte.1959.00270050084014.Search in Google Scholar

4. Mannucci PM, Franchini M. Is haemophilia B less severe than haemophilia A? Haemophilia 2013; 19: 499P502. doi: 10.1111/hae.12133.Search in Google Scholar

5. Reijnen MJ, Sladek FM, Bertina RM, Reitsma PH. Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden. Proc Natl Acad Sci USA. 1992; 89: 6300P3.10.1073/pnas.89.14.6300Search in Google Scholar

6. Nathwani AC, Tuddenham EG, Rangarajan S, et al. AdenovirusPassociated virus vectorPmediated gene transfer in hemophilia B. N Engl J Med 2011; 365: 2357P65. doi: 10.1056/NEJMoa1108046.Search in Google Scholar

7. Nathwani AC, Reiss UM, Tuddenham EG, Rosales C, Chowdary P, McIntosh J, et al. LongPterm safety and efficacy of factor IX gene therapy in hemophilia B. N Engl J Med 2014; 371: 1994P2004. doi: 10.1056/NEJMoa1407309.Search in Google Scholar

8. Collins PW, Young G, Knobe K, et al. Recombinant longPacting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial. Blood First Edition Paper, prepublished online September 26, 2014; DOI 10.1182/bloodP2014P 05P57305510.1182/blood-2014-05-573055Search in Google Scholar

Publication timeframe:
Volume Open
Journal Subjects:
Medicine, Basic Medical Science, other, Clinical Medicine, Pharmacy, Pharmacology